ArticleOpen medicine (Warsaw, Poland)2023

Midazolam impedes lung carcinoma cell proliferation and migration via EGFR/MEK/ERK signaling pathway.

Xiangchao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.